Eicarte LLC is a preclinical toxicology consultancy that specializes in overseeing comprehensive preclinical toxicology development programs for pharmaceutical drug candidates. The company focuses on providing expert advice regarding toxicity profiles, emphasizing a benefit versus risk analysis. Their expertise lies in the interpretation of systems-based toxicities, which is crucial for understanding the potential adverse effects of drug candidates before they proceed to clinical trials. This approach ensures that clients receive informed guidance on managing and resolving preclinical toxicology challenges effectively and efficiently.

The consultancy is led by Tracie E. Bunton, who holds a DVM, PhD, and DACVP, indicating a high level of expertise in veterinary pathology and toxicology. Eicarte LLC is committed to meeting aggressive timelines while delivering confident management of toxicology issues, which is essential for pharmaceutical companies aiming to bring safe and effective drugs to market. Their focus on preclinical stages highlights the importance of thorough toxicological assessments in the drug development process, ultimately contributing to the safety and efficacy of new pharmaceutical products.

United States

With an integrated understanding of pharmacology, toxicology and medicine based on education and experience, Eicarte will assist in the decisions which will smooth the transition through the phases of drug discovery and development.

Eicarte LLC

Company Details